Disruptive Behavior Disorders Clinical Trial
— TE-HNCOfficial title:
Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
Verified date | June 2021 |
Source | University of North Carolina, Chapel Hill |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to the test the efficacy and cost effectiveness of new service delivery methods to enhance the reach and impact of the standard of care treatment, Behavioral Parent Training (BPT), for early onset disruptive behavior disorders.
Status | Completed |
Enrollment | 101 |
Est. completion date | August 2019 |
Est. primary completion date | August 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Years to 7 Years |
Eligibility | Inclusion Criteria: - Child aged 3 to 7 years - has clinically significant disruptive behaviors - low-income family Exclusion Criteria: - Caregiver has current mood, substance use, and/or psychotic disorder - Child has current pervasive developmental and/or psychotic disorder - Family has current allegation and/or past substantiation with child protective services |
Country | Name | City | State |
---|---|---|---|
United States | UNC Department of Psychology | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Engagement | Engagement includes multiple dimensions of participation in the treatment process, including items assessing attendance at weekly sessions, participation in mid-week calls, and home practice of skills. | Participants will be followed for the duration of treatment, an expected average of 10 weeks | |
Secondary | Change in Disruptive Behavior from the start of treatment through 6 months after treatment ends | Disruptive behavior includes multiple dimensions of behavior, including items assessing noncompliance, aggression, and oppositionality. | Participants will be followed through the duration of treatment and 6 additional months after treatment ends, an expected average of 9 months | |
Secondary | Treatment Cost | Cost is a multidimensional measure that includes items assessing both start-up (e.g., technology development) and implementation (e.g., therapist time) costs. | Treatment costs will be tracked through the duration of treatment, an expected average of 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02543359 -
A Statewide Trial to Compare Three Training Models for Implementing an Evidence-based Treatment (EBT)
|
N/A | |
Completed |
NCT04113304 -
The Parenting Young Children Check-up: Proof-of-Concept Trial
|
||
Completed |
NCT01463241 -
Behavioral and Affective Skills in Coping (BASIC) Open Trial
|
N/A | |
Completed |
NCT02824627 -
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
|
Phase 2 |